Bayer | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Air Liquide EUR 1.92B 0 2025-06
Akzo Nobel EUR 1.55B 47M 2025-06
Alcon AG USD 1.41B 417M 2025-03
Amarin USD 119.52M 1.51M 2025-03
Arkema EUR 1.12B 895M 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
BASF EUR 2.52B 203M 2025-06
Bayer EUR 4.56B 542M 2025-06
Beiersdorf EUR 1.17B 40M 2025-06
Corteva USD 2.06B 57M 2025-06
Covestro EUR 489M 253M 2025-06
Essilor EUR 2.25B 86M 2024-12
Fresenius EUR 1.23B 1.16B 2025-06
Fresenius Medical Care EUR 1.72B 644.08M 2025-06
Genmab DKK 1.3B 323M 2025-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
GRIFOLS EUR 558.69M 194.13M 2025-06
Henkel EUR 2.87B 18M 2025-06
Hikma Pharmaceutical USD 188M 188M 2024-12
Johnson Matthey GBP 898M 277M 2025-03
Linde USD 4.85B 337M 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck EUR 1.17B 161M 2025-06
Novartis USD 6.66B 410M 2025-06
Nutrien USD 1.23B 333M 2025-06
Philips EUR 1.82B 629M 2025-06
PPG Industries USD 1.56B 269M 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 15.36B 7.37B 2025-06
SAP EUR 7.94B 3.4B 2025-06
Solvay EUR 333M 118M 2025-06
UCB EUR 1.57B 1.14B 2024-12
Umicore EUR 2.01B 712.6M 2024-12
Vinci EUR 15.07B 130M 2025-06


Bayer Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.